Skip to main content

When cardioverting patients in new atrial fibrillation, we want our first attempt to be our best attempt.

The Study
Schmidt A S. Antero-Lateral Versus Anterior-Posterior Electrode Position for Converting Atrial Fibrillation. Circulation. 2021;144:1995–2003.

The EPIC Trial(1) (Electrode Position In cardioverting Atrial Fibrillation) helps us answer not only the question of pad position, but also energy selection.

What they did

This was a multicentre, investigator initiated, randomised open-label, blinded-outcome assessment trial.

N= 468

Patients in this study were adult patients that were having elective cardioversion, with biphasic defibrillators. They were randomised to anterior-lateral or anterior-posterior pad placemant.

Synchronised biphasic shocks were delivered.

Escalating energy was used: 110J, 150J 200J and 360J.

Primary Outcome: Proportion of patients in sinus rhythm 1 minute after shock.

Secondary outcomes:

  • Proportion of patients in sinus rhythm 1 minute after final shock delivered(maximum of 4 cardioversion shocks).
  • Cardioversion efficacy 2 hours after cardioversion.

Safety outcomes included:

  • Arrhythmias: asystole, atrioventricular blocks, transient bradycardia or ventricular arrhythmias
  • Skin redness under electrodes
  • Pain score by patient

What they found

Primary outcome ie patients in sinus rhythm 1 minute after the first shock was

  • 54%(126 patients) in the antero-lateral position
  • 33%(77) in the antero-posterior position

The number of patients in sinus rhythm after the final shock was:

  • 93%(216 patients) in the anterior-lateral position and
  • 85% (200 patients) in the anterior-posterior position.
  • This translated to the number needed to treat of 14.

Use of the anterior-lateral position resulted in a significantly lower number of shocks needed.

There were no differences in safety outcomes.

My Take on This

This one is simple and helps shape clinical practice. The RAFF-2 trial(1) one year earlier, showed no difference in terms of pad positioning, the results here have changed my practice. I use anterior-lateral positioning of pads. Certainly I may change the pads ifI can’t cardiovert the patient in the first 2 shocks. Would you change pad positioning?

References

  1. Stiell IG et al. Electrical Versus Pharmacological Cardioversion for Emergency Department Patients with Acute Atrial Fibrillation (RAFF2): A Partial Factorial Randomised Trial. Lancet 2020. PMID: 32007169

Leave a Reply